Sector not mapped · coverage Apr 28, 2025–Apr 3, 2026
Estimated market comparison · not an official filing fact
Available with Pro
Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.
Disclosure alert preview
Based on a real public filing
Kevin Hern
$15K - $50K
This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Aug 13, 2026.
Official filingThis page summarizes public STOCK Act disclosures involving IVZ. It is useful for seeing which lawmakers reported IVZ transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Apr 3, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
Congressional Trader tracks 3 public STOCK Act disclosures for IVZacross 3 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent IVZ filing shown here was filed on Apr 3, 2026 by Kevin Hern as a sale. Related lawmakers include Gilbert Ray Cisneros, Kevin Hern, Robert P. Bresnahan.
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansRecent IVZ disclosures include Gilbert Ray Cisneros, Kevin Hern, Robert P. Bresnahan.
The visible sample currently shows 1 purchases and 2 sales or partial sales.
No. This page summarizes public filings for research and monitoring. It is not investment advice.
